Literature DB >> 33692217

Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.

Zhengjun Zhou1, Pengcheng Wang1, Rongqi Sun1, Jia Li1, Zhiqiang Hu1, Haoyang Xin1, Chubin Luo1, Jian Zhou1, Jia Fan1, Shaolai Zhou2.   

Abstract

BACKGROUND: Tumor-associated neutrophils (TANs) and macrophages (TAMs) can each influence cancer growth and metastasis, but their combined effects in intrahepatic cholangiocarcinoma (ICC) remain unclear.
METHODS: We explored the distributions of TANs and TAMs in patient-derived ICC samples by multiplex immunofluorescent staining and tested their separate and combined effects on ICC in vitro and in vivo. We then investigated the mechanistic basis of the effects using PCR array, western blot analysis and ELISA experiments. Finally, we validated our results in a tissue microarray composed of primary tumor tissues from 359 patients with ICC.
RESULTS: The spatial distributions of TANs and TAMs were correlated with each other in patient-derived ICC samples. Interaction between TANs and TAMs enhanced the proliferation and invasion abilities of ICC cells in vitro and tumor progression in a mouse xenograft model of ICC. TANs and TAMs produced higher levels of oncostatin M and interleukin-11, respectively, in co-culture than in monoculture. Both of those cytokines activated STAT3 signaling in ICC cells. Knockdown of STAT3 abolished the protumor effect of TANs and TAMs on ICC. In tumor samples from patients with ICC, increased TAN and TAM levels were correlated with elevated p-STAT3 expression. All three of those factors were independent predictors of patient outcomes.
CONCLUSIONS: TANs and TAMs interact to promote ICC progression by activating STAT3. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  cytokines; liver neoplasms; macrophages; neutrophil infiltration; tumor microenvironment

Mesh:

Substances:

Year:  2021        PMID: 33692217      PMCID: PMC7949476          DOI: 10.1136/jitc-2020-001946

Source DB:  PubMed          Journal:  J Immunother Cancer        ISSN: 2051-1426            Impact factor:   13.751


  28 in total

Review 1.  Cholangiocarcinoma: current concepts and insights.

Authors:  Gregory J Gores
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 2.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Authors:  William C Palmer; Tushar Patel
Journal:  J Hepatol       Date:  2012-03-13       Impact factor: 25.083

3.  A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression.

Authors:  Shao-Lai Zhou; Dan Yin; Zhi-Qiang Hu; Chu-Bin Luo; Zheng-Jun Zhou; Hao-Yang Xin; Xin-Rong Yang; Ying-Hong Shi; Zheng Wang; Xiao-Wu Huang; Ya Cao; Jia Fan; Jian Zhou
Journal:  Hepatology       Date:  2019-05-15       Impact factor: 17.425

Review 4.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

5.  Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

Authors:  Lore Lapeire; An Hendrix; Kathleen Lambein; Mieke Van Bockstal; Geert Braems; Rudy Van Den Broecke; Ridha Limame; Pieter Mestdagh; Jo Vandesompele; Christian Vanhove; Dawn Maynard; Camille Lehuédé; Catherine Muller; Philippe Valet; Christian P Gespach; Marc Bracke; Veronique Cocquyt; Hannelore Denys; Olivier De Wever
Journal:  Cancer Res       Date:  2014-09-24       Impact factor: 12.701

6.  Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.

Authors:  Xin-Da Zhou; Zhao-You Tang; Jia Fan; Jian Zhou; Zhi-Quan Wu; Lun-Xiu Qin; Zeng-Chen Ma; Hui-Chuan Sun; Shuang-Jian Qiu; Yao Yu; Ning Ren; Qing-Hai Ye; Lu Wang; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

7.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

Review 8.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

9.  A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

Authors:  Shicheng Su; Qiang Liu; Jingqi Chen; Jianing Chen; Fei Chen; Chonghua He; Di Huang; Wei Wu; Ling Lin; Wei Huang; Jin Zhang; Xiuying Cui; Fang Zheng; Haiyan Li; Herui Yao; Fengxi Su; Erwei Song
Journal:  Cancer Cell       Date:  2014-05-12       Impact factor: 31.743

10.  Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.

Authors:  Shao-Lai Zhou; Zheng-Jun Zhou; Zhi-Qiang Hu; Cheng-Li Song; Yi-Jie Luo; Chu-Bin Luo; Hao-Yang Xin; Xin-Rong Yang; Ying-Hong Shi; Zheng Wang; Xiao-Wu Huang; Ya Cao; Jia Fan; Jian Zhou
Journal:  J Hepatol       Date:  2019-07-23       Impact factor: 25.083

View more
  10 in total

1.  MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.

Authors:  Richard E Kast; Alex Alfieri; Hazem I Assi; Terry C Burns; Ashraf M Elyamany; Maria Gonzalez-Cao; Georg Karpel-Massler; Christine Marosi; Michael E Salacz; Iacopo Sardi; Pieter Van Vlierberghe; Mohamed S Zaghloul; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

Review 2.  The Functional Roles of Immune Cells in Primary Liver Cancer.

Authors:  Linh Pham; Konstantina Kyritsi; Tianhao Zhou; Ludovica Ceci; Leonardo Baiocchi; Lindsey Kennedy; Sanjukta Chakraborty; Shannon Glaser; Heather Francis; Gianfranco Alpini; Keisaku Sato
Journal:  Am J Pathol       Date:  2022-03-23       Impact factor: 5.770

3.  The spatial distribution of immune cell subpopulations in hepatocellular carcinoma.

Authors:  Peng-Cheng Wang; Zhi-Qiang Hu; Shao-Lai Zhou; Song-Yang Yu; Li Mao; Sheng Su; Jia Li; Ning Ren; Xiao-Wu Huang
Journal:  Cancer Sci       Date:  2021-12-13       Impact factor: 6.716

Review 4.  Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).

Authors:  Ranzhiqiang Yang; Yinghui Song; Kashif Shakoor; Weimin Yi; Chuang Peng; Sulai Liu
Journal:  Mol Med Rep       Date:  2022-03-18       Impact factor: 2.952

Review 5.  Role of macrophages in tumor progression and therapy (Review).

Authors:  Yiwei Xu; Xiaomin Wang; Lijuan Liu; Jia Wang; Jibiao Wu; Changgang Sun
Journal:  Int J Oncol       Date:  2022-04-01       Impact factor: 5.650

Review 6.  Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment.

Authors:  Shilin Wang; Guohong Liu; Yirong Li; Yunbao Pan
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 7.  Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer.

Authors:  Alessandra Caligiuri; Stefano Gitto; Giulia Lori; Fabio Marra; Maurizio Parola; Stefania Cannito; Alessandra Gentilini
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

8.  Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.

Authors:  Jian Lin; Yuting Dai; Chen Sang; Guohe Song; Bin Xiang; Mao Zhang; Liangqing Dong; Xiaoli Xia; Jiaqiang Ma; Xia Shen; Shuyi Ji; Shu Zhang; Mingjie Wang; Hai Fang; Xiaoming Zhang; Xiangdong Wang; Bing Zhang; Jian Zhou; Jia Fan; Hu Zhou; Daming Gao; Qiang Gao
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

Review 9.  Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.

Authors:  Hengsong Cao; Tian Huang; Mingrui Dai; Xiangyi Kong; Hanyuan Liu; Zhiying Zheng; Guoqiang Sun; Guangshun Sun; Dawei Rong; Zehua Jin; Weiwei Tang; Yongxiang Xia
Journal:  Int J Biol Sci       Date:  2022-08-21       Impact factor: 10.750

Review 10.  Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.

Authors:  Kyoko Oura; Asahiro Morishita; Joji Tani; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.